Atlas Trials

HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19

Clinical trial NCT05963958 · COMPLETED

Trial details

NCT number
NCT05963958
Sponsor
Suellen Andrade
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19DeliriumCritical Illness
Start date
2021-04-14
Primary completion
2022-12-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.